RESUMEN
PURPOSE: In this study, we assessed the relationship between remnant gastritis and muscle mass loss and then investigated the potential relationship between Helicobacter pylori (HP) infection and remnant gastritis and muscle loss. METHODS: We reviewed the medical records of 463 patients who underwent distal gastrectomy between January 2017 and March 2020. Of these patients, 100 with pStage I after laparoscopic surgery were included in this analysis. RESULTS: A multivariate analysis showed that the total Residue, Gastritis, Bile (RGB) classification score, which indicates the degree of gastritis, was significantly associated with the rate of change (rate of decrease) in the psoas muscle area (PMA) during the first 6 months after surgery (p = 0.014). Propensity score matching was performed according to HP infection, and the rate of change in the PMA and the degree of remnant gastritis in 56 patients were compared. Neither was significantly associated with HP infection. CONCLUSIONS: Remnant gastritis did contribute to psoas muscle mass loss during the initial 6 months after gastrectomy, and HP infection was not significantly associated with either remnant gastritis or psoas muscle mass loss. Nevertheless, the potential for HP eradication to prevent muscle loss and improve the survival prognosis for gastrectomy patients merits further research.
Asunto(s)
Gastritis , Infecciones por Helicobacter , Helicobacter pylori , Neoplasias Gástricas , Humanos , Gastrectomía/efectos adversos , Mucosa Gástrica , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/cirugía , Músculos , Estudios Retrospectivos , Neoplasias Gástricas/cirugía , Neoplasias Gástricas/complicacionesRESUMEN
Gastric cancer is one of the most lethal malignancies worldwide. Chronic Helicobacter pylori (H. pylori) infection can induce an inflammatory response that promotes atrophic gastritis, a preceding event to cancer development. The type 1 regulatory T (Tr1) cells have recently emerged as a critical participant in maintaining self-tolerance. In this study, we examined Tr1 cells in H. pylori infection and gastric cancer development. While H. pylori-uninfected (uninfected) subjects presented low Tr1 frequency in the peripheral blood, H. pylori-infected asymptomatic (infected) individuals and H. pylori-infected gastric cancer (cancer) individuals both presented elevated Tr1 frequency. Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation. In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients. These results suggest that Tr1 cells might be involved in the regulating immune responses in H. pylori infection and gastric cancer development. The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.
Asunto(s)
Infecciones por Helicobacter/inmunología , Helicobacter pylori , Neoplasias Gástricas/inmunología , Linfocitos T Reguladores/inmunología , Adulto , Anciano , Antígenos CD/análisis , Infecciones Asintomáticas , Supervivencia sin Enfermedad , Femenino , Factores de Transcripción Forkhead/análisis , Infecciones por Helicobacter/cirugía , Humanos , Integrina alfa2/análisis , Interleucina-10/análisis , Masculino , Persona de Mediana Edad , Pronóstico , Neoplasias Gástricas/cirugía , Proteína del Gen 3 de Activación de LinfocitosRESUMEN
Despite major breakthroughs in the field of personalized medicine, gastric cancer (GC) remains a clinically challenging disease, characterized by scarce effective treatment options and the lack of reliable molecular tools for the prediction of patient outcome and response to therapy. The pronounced molecular heterogeneity that dictates the phenotypical aggressiveness of gastric neoplasms severely limits the antitumor efficacy of targeted agents brought to clinical trials, and constitutes a favorable setting for the emergence of refractory tumors exhibiting multidrug resistance. We will review the most recent advances in our understanding of GC biology, which are underlying the development and clinical testing of novel targeted therapeutic agents. We will also emphasize how their efficacy and acquired resistance relate to the aberrant molecular signatures that drive gastric malignancy.
Asunto(s)
Infecciones por Helicobacter/patología , Neoplasias Gástricas/patología , Animales , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/cirugía , Humanos , Neoplasias Gástricas/tratamiento farmacológico , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/cirugíaRESUMEN
BACKGROUND: Gastrointestinal endoscopy and Helicobacter pylori(H. pylori) eradication therapy are commonly performed even among the elderly population. The aim of this study was to understand the way endoscopists viewed the application of endoscopy and H. pylori eradication in the elderly of East Asian countries. METHODS: Self-administered questionnaires containing 13 questions on endoscopy and H. pylori eradication in the elderly were distributed to major institutions in Japan, South Korea, China, Indonesia, and the Philippines. RESULTS: Two hundred and fifteen endoscopists (111 in Japan, 39 in China, 24 in Korea, 21 in Indonesia, and 20 in the Philippines) participated in this study. In the institutions where these endoscopists were associated, around 50% of patients undergoing endoscopy were above the age of 60 years. The participating endoscopists indicated that the necessity of screening esophagogastroduodenoscopy and colonoscopy was lower in populations aged over 81 than the other age groups. They hesitated to perform therapeutic endoscopy, such as endoscopic submucosal dissection or endoscopic retrograde cholangiopancreatography, more often in patients over 85. They also hesitated to perform H. pylori eradication in patients aged over 81, especially in Japan. CONCLUSION: Endoscopists had significantly different attitudes regarding the indications for screening or therapeutic endoscopy and H. pylori eradication therapy in younger and elderly populations in East Asian countries.
Asunto(s)
Endoscopía del Sistema Digestivo/métodos , Infecciones por Helicobacter/diagnóstico , Anciano , Anciano de 80 o más Años , China , Colonoscopía/métodos , Disección , Mucosa Gástrica/patología , Mucosa Gástrica/cirugía , Gastroenterología , Infecciones por Helicobacter/cirugía , Helicobacter pylori , Humanos , Indonesia , Mucosa Intestinal/patología , Mucosa Intestinal/cirugía , Japón , Persona de Mediana Edad , Filipinas , República de Corea , Encuestas y CuestionariosRESUMEN
The discovery of Helicobacter pylori (H. pylori) represents one of the most notable events in the field of experimental and clinical medicine with great impact to daily practice even to surgery. It has led to a paradigm shift in the treatment of peptic ulcer disease. For the time period of almost one century, several scientists had described spiral-shaped bacteria in the stomach of animals and humans. However, it lasted till the early 1980s when Robin Warren and Barry Marshall successfully cultured H. pylori and recognised its causal relationship to chronic gastritis and peptic ulcer disease. Since then, our knowledge about H. pylori and related diseases has been continuously growing. Today, the bacterium is known to be mainly responsible for the development of chronic gastritis, peptic ulcer disease, MALT lymphoma and is considered as the main risk factor for the development of gastric cancer - all this led to a switch in the basic aetiopathogenetic considerations. In particular, eradication of H. pylori helped to i) develop an aetiology-based therapeutic and preventive approach to the diseases listed above according and adapted to findings, stage and manifestation, and ii) define a new role of surgery in the treatment concept. In addition, more and more evidence is being gathered for a possible association between the bacterium and several extragastric diseases.
Asunto(s)
Úlcera Duodenal/diagnóstico , Úlcera Duodenal/cirugía , Gastritis/diagnóstico , Gastritis/cirugía , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/cirugía , Helicobacter pylori , Linfoma de Células B de la Zona Marginal/diagnóstico , Linfoma de Células B de la Zona Marginal/cirugía , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/cirugía , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/cirugía , Progresión de la Enfermedad , Úlcera Duodenal/prevención & control , Gastritis/prevención & control , Infecciones por Helicobacter/prevención & control , Humanos , Linfoma de Células B de la Zona Marginal/prevención & control , Neoplasias Gástricas/prevención & control , Úlcera Gástrica/prevención & controlRESUMEN
In 213 patients with gastric and duodenal pathology, including received surgery, comparative estimation of results of Helicobacter pylori (Hp) infection testing with invasive and noninvasive methods, were performed. Material for invasive endoscopic biopsy test (EBT), including rapid urease test (RUT) for rapid Hp identification by determination of urease activity, smear cytology and histology was extracted on endoscopy or intraoperationally. RUT was carried out with the help of URE-HP test kit. Serological test for Hp antibodies IgG and IgA class was performed by IFA using kit ELISA. 13С urea breath test (UBT) was made by determination of 13/12CO2 in breath samples on infrared spectroscope. Based on 5 different methods of Hp infection testing Hp positivity in 172 (80,8%) and Hp negativity in 41 (19,2%) from 213 examined patients was revealed. 13С-UBT revealed the highest diagnostic value (accuracy-97,5%, sensibility-97,0%, specificity-100%) in Hp infection diagnostics. In treatment efficiency control this parameters of 13С-UBT are also much high (96,7%, 90,0% and 100% respectively). In spite of high sensitivity of serological test (100%), it had comparative low specificity (71,0%) with high probability of false positive results in treated patients (antibodies titer to Hp after eradication retains for a long time). Thought, this test may be successfully used only in primary patients and in epidemiological studies. Among three methods of EBT, Hp infection detection with RUT revealed the best results (accuracy-94,8%, sensibility-95,0%, specificity-100%). Correlation of RUT and UBT results and much higher diagnostic value of UBT, necessitate RUT with histological study of stomach body mucosa to perform in patients over 45 year, with prolonged anamnesis and dangerous symptoms of disease. In Hp positive patients correlation of index DOB of breath test with results of RUT was revealed. This can serve the index DOB of 13С-UBT as a marker of Hp infection rate. The (accuracy, sensibility and specificity of breath test with local made 13С-urea (98,7%, 98,5% and 100% respectively) are the same as those for BT with standard 13С-urea (96,7%, 96,2% and 100% respectively). Above mentioned, 13С-UBT advantages (noninvasiveness, simplicity, rapidity, safety) and high diagnostic value exceeding same of other applied tests, give us opportunity to offer 13С-UBT as screening method of Hp infection diagnosis and a method of choise in control of Hp infection treatment efficiency.
Asunto(s)
Endoscopios Gastrointestinales , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Femenino , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/patogenicidad , Humanos , Masculino , Valor Predictivo de las Pruebas , Pruebas SerológicasRESUMEN
Analyzed long-term outcomes of 690 patients with duodenal ulcer, complicated by bleeding in Kyiv City Centre gastrointestinal bleeding for the periods 1994-1996 (control group) and 2004-2008 (main group). In the late period of patients who were found giperhlorgidry (moderate and severe), increased by 1.4 tImes, indicating a higher voltage continuous acid production In the main group. With the introduction of modern circuits Helicobacter therapy incidence of H. pylori reduced by half. Improving modern tactical approaches to conservative treatment helped to reduce the frequency of relapses in duodenal ulcer remote period by 2.2 times, acute bleeding--in 1.9 times, increase the frequency of excellent results--in 2.8 times.
Asunto(s)
Úlcera Duodenal/cirugía , Infecciones por Helicobacter/cirugía , Úlcera Péptica Hemorrágica/cirugía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Úlcera Duodenal/complicaciones , Úlcera Duodenal/tratamiento farmacológico , Úlcera Duodenal/microbiología , Femenino , Ácido Gástrico/metabolismo , Determinación de la Acidez Gástrica , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/microbiología , Helicobacter pylori/efectos de los fármacos , Helicobacter pylori/fisiología , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica Hemorrágica/complicaciones , Úlcera Péptica Hemorrágica/tratamiento farmacológico , Úlcera Péptica Hemorrágica/microbiología , Estudios Retrospectivos , Prevención Secundaria , Resultado del Tratamiento , UcraniaRESUMEN
Reflux esophagitis and gastric tube ulcer sometimes cause severe clinical problems in patients undergoing esophagectomy with gastric tube reconstruction. We previously reported that acidity in the gastric tube was decreased for 1 year after esophagectomy, and that lower acidity levels were associated with Helicobacter pylori (H. pylori) infection. However, the long-term changes in gastric acidity remain unknown. We aimed to investigate the long-term changes in gastric acidity after surgery. Eighty-nine patients who underwent esophagectomy with gastric tube reconstruction for esophageal cancer were analyzed. They underwent 24-hour pH monitoring, serum gastrin measurement, and H. pylori infection examination before surgery, at 1 month, 1 year, and 2 years after surgery. The gastric acidity at 1 month and 1 year after surgery was significantly lower than that before surgery (p=0.003, p=0.003). However, there was no difference in gastric acidity before and 2 years after surgery. The gas tric acidity in H. pylori-infected patients was significantly lower in comparison to non-infected patients at each time point (p=0.0003, p<0.0001, p<0.0001, p<0.0001, respectively). In H. pylori-infected patients, gastric acid ity was decreased for 1 year after surgery, and recovered within 2 years after surgery. However, no significant differences were observed in the acidity levels of non-infected patients during the 2-year follow-up period. The serum gastrin level increased after esophagectomy. The acidity levels in the gastric tube recovered within 2 years after surgery. Periodic endoscopy examination is recommended for early detection of acid-related disease, such as reflux esophagitis or gastric tube ulcer, after esophagectomy with gastric tube reconstruction.
Asunto(s)
Neoplasias Esofágicas , Esofagitis Péptica , Infecciones por Helicobacter , Humanos , Esofagectomía/efectos adversos , Esofagitis Péptica/etiología , Esofagitis Péptica/cirugía , Gastrinas , Úlcera/complicaciones , Úlcera/cirugía , Neoplasias Esofágicas/cirugía , Neoplasias Esofágicas/complicaciones , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/cirugíaRESUMEN
BACKGROUND: The most common complications of peptic ulcer are bleeding and perforation. In many regions, definitive acid reduction surgery has given way to simple closure and Helicobacter pylori eradication. AIM: To perform a systematic review and meta-analysis to ask whether this change in practice is in fact justified. MATERIALS AND METHODS: A search on the Cochrane Controlled Trials Register, Medline, and Embase was made for controlled trials of duodenal ulcer perforation patients using simple closure method plus postoperative H. pylori eradication therapy versus simple closure plus antisecretory non-eradication therapy. The long-term results for prevention of ulcer recurrence were compared. RESULTS: The pooled incidence of 1-year ulcer recurrence in H. pylori eradication group was 5.2% [95% confidence interval (CI) of 0.7 and 9.7], which is significantly lower than that of the control group (35.2%) with 95% CI of 0.25 and 0.45. The pooled relative risk was 0.15 with 95% CI of 0.06 and 0.37. CONCLUSIONS: Helicobacter pylori eradication after simple closure of duodenal ulcer perforation gives better result than the operation plus antisecretory non-eradication therapy for prevention of ulcer recurrence. All duodenal ulcer perforation patients should be tested for H. pylori infection, and eradication therapy is required in all infected patients.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/cirugía , Úlcera Péptica Perforada/tratamiento farmacológico , Úlcera Péptica Perforada/cirugía , Infecciones por Helicobacter/microbiología , Helicobacter pylori/aislamiento & purificación , Helicobacter pylori/fisiología , Humanos , Úlcera Péptica Perforada/microbiología , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
INTRODUCTION: Helicobacter species have recently been found to be associated with some diseases of the biliary tree but this relationship remains unclear and further studies are required. The aim of this study was to determine the presence of H. pylori-type bacteria in patients with a diagnosis of chronic cholecystitis through histopathological study of surgical gallbladder specimens. MATERIALS AND METHODS: Surgical gallbladder specimens from patients with a diagnosis of chronic cholecystitis were examined histopathologically. The macroscopic characteristics of the specimens were identified. Histopathological slices were stained with hematoxylin-eosin and Giemsa. RESULTS: Of the 68 patients who underwent cholecystectomy, 56 (81%) were women and 12 (19%) were men. The mean age was 39.56+11.94 years. H. pylori-type bacteria were found in 6%. CONCLUSIONS: The results of this study do not allow us to conclude that the presence of H. pylori-type bacteria is a major factor in the etiology and/or pathogenesis of chronic cholecystitis. In patients with chronic cholecystitis undergoing cholecystectomy included in the present study, the etiology of the disease may be more closely linked with the presence of gallstones.
Asunto(s)
Colecistitis/microbiología , Infecciones por Helicobacter/microbiología , Helicobacter pylori/aislamiento & purificación , Adulto , Colecistectomía , Colecistitis/patología , Colecistitis/cirugía , Colelitiasis/microbiología , Colelitiasis/cirugía , Colesterol/análisis , Enfermedad Crónica , Femenino , Fibrosis , Vesícula Biliar/química , Vesícula Biliar/microbiología , Vesícula Biliar/patología , Infecciones por Helicobacter/patología , Infecciones por Helicobacter/cirugía , Humanos , Hipertrofia , Masculino , Persona de Mediana Edad , Músculo Liso/microbiología , Músculo Liso/patologíaRESUMEN
CONTEXT.: Laparoscopic sleeve gastrectomy (LSG) has quickly become the bariatric surgical procedure of choice for patients with obesity who have failed medical management. Laparoscopic sleeve gastrectomy results in a gastric remnant that is routinely subject to pathologic examination. OBJECTIVE.: To perform a histologic and cost-benefit analysis of gastric remnants post-LSG. DESIGN.: All LSG cases performed at University Health Network, Toronto, Ontario, Canada, between 2010 and 2019 were reviewed. Specimens that underwent routine histopathologic assessment and ancillary immunohistochemical analysis were analyzed. Baseline patient characteristics and surgical outcomes were obtained from our internal database. The total cost of specimen gross preparation, examination, sampling, and producing and reporting a hematoxylin-eosin slide was calculated. RESULTS.: A total of 572 patients underwent LSG during the study period and had their specimens examined histologically. A mean of 4.87 blocks generating 4 hematoxylin-eosin slides was produced. The most common histologic findings reported in LSG specimens ranged from no pathologic abnormalities identified together with proton pump inhibitor-related change. A minority of cases demonstrated clinically actionable histologic findings, of which Helicobacter pylori infection was the most common. The total cost for the complete pathologic analysis of these cases amounted to CaD $66 383.10 (US $47 080.21) with a mean of CaD $116.05 (US $82.40) per case. A total of CaD $62 622.75 (US $44 413.30) was spent on full examination of cases that had no further postoperative clinical impact. CONCLUSIONS.: There is a broad spectrum of pathologic findings in LSG specimens, ranging from clinically nonactionable to more clinically actionable. The vast majority of histologic findings had no clinical impact, with only a minority of cases being clinically significant. This study therefore recommends that LSG specimens be subject to gross pathologic examination in the vast majority of cases. However, sections should be submitted for microscopic analysis if grossly evident lesions are present and if there is a clinical/known history of clinically actionable findings.
Asunto(s)
Gastrectomía/economía , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Laparoscopía/economía , Obesidad Mórbida/patología , Adulto , Cirugía Bariátrica , Análisis Costo-Beneficio , Femenino , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/cirugía , Humanos , Masculino , Persona de Mediana Edad , Obesidad Mórbida/diagnóstico , Obesidad Mórbida/cirugía , OntarioRESUMEN
INTRODUCTION: This work reports a patient with recurrent renal calculi subjected to three surgeries in half a year to be in the same position, and the high-throughput sequencing data showed different species in the renal pus and urine samples, which suggested that partial renal infection or stone formation can be judged by the bacteria in urine. PATIENT CONCERNS: The female patient aged 43 years was referred to the authors' department on April 13, 2020, due to left waist pain and fever for 3 days. DIAGNOSIS: Kidney stones and hydronephrosis were determined by a urinary system computed tomography scan. INTERVENTIONS: On April 20, 2020 and June 15, 2020, the patient was successfully treated with left percutaneous nephrolithotomy twice under general anesthesia. An investigation on the health and eating habits of the patient within 6 months was completed at the last admission. The components of the second renal calculus sample were analyzed with an infrared spectrum analyzer. The third renal stone (renal pus, triplicates) was subjected to microbial metagenome sequencing, and urine samples before and after surgery were subjected to 16S RNA sequencing by SEQHEALTH (Wuhan, China). OUTCOMES: After percutaneous nephrolithotomy, the left kidney stones were basically cleared, stone analysis revealed that the main components were calcium oxalate monohydrate, silica, and a small amount of calcium oxalate dehydrate. Although the urine samples exhibited differences, the renal pus and urine sample shared a single species. CONCLUSION: It is not clear that the prospects of partial renal infection or stone formation can be judged by the bacteria in urine.
Asunto(s)
Infecciones por Helicobacter/diagnóstico , Hidronefrosis/diagnóstico , Cálculos Renales/diagnóstico , Nefrolitotomía Percutánea/efectos adversos , Infecciones Urinarias/diagnóstico , Adulto , ADN Bacteriano/aislamiento & purificación , Femenino , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/cirugía , Helicobacter pylori , Humanos , Hidronefrosis/microbiología , Hidronefrosis/cirugía , Cálculos Renales/microbiología , Cálculos Renales/cirugía , Metagenoma/genética , ARN Ribosómico 16S/genética , Recurrencia , Reoperación , Infecciones Urinarias/complicaciones , Infecciones Urinarias/microbiología , Infecciones Urinarias/cirugíaRESUMEN
BACKGROUND: The incidence of gastric cancers has fallen in recent decades. However, a substantial reduction in Helicobacter pylori prevalence and a substantial increase in the incidence of proximal gastric cancer (PGC) have been observed in the West and Japan, but not in other East Asian countries. The purpose of this large-volume study was to analyze prevalence, clinicopathological features, and prognosis of PGC compared with other types of gastric cancer in Korea, where there is high incidence of H. pylori infection. METHODS: Between 2000 and 2005, a total of 3,193 patients were enrolled. We analyzed clinicopathological features and survival outcomes. RESULTS: Chronological analysis showed increasing incidence of PGC over the study period. PGC patients were younger and had higher incidence of Bormann types III and IV than did distal gastric cancer (DGC) patients. Also, PGC was associated with a significantly higher proportion of poorly differentiated type, T3 and T4 stage, and positive lymph nodes compared with DGC. Peritoneal and other distant metastases were more common in PGC group than in DGC group. The 5-year survival rate was significantly lower in PGC than in DGC group, regardless of curative resection. Also, the N0 and N1 category significantly influenced the 5-year survival rate. Tumor-node-metastasis (TNM) stage, hepatic metastasis, and curative resection were significant prognostic factors in PGC patients. CONCLUSIONS: PGC has increased in incidence with the respective decline in H. pylori prevalence in Korea. Survival was worse for patients with PGC than for those with DGC, regardless of curative respectability. PGC is often diagnosed at more advanced stage than other gastric cancers, and therefore early detection is critical for successful treatment.
Asunto(s)
Carcinoma de Células en Anillo de Sello/patología , Infecciones por Helicobacter/patología , Helicobacter pylori/patogenicidad , Neoplasias Hepáticas/secundario , Neoplasias Peritoneales/secundario , Neoplasias Gástricas/patología , Carcinoma de Células en Anillo de Sello/microbiología , Carcinoma de Células en Anillo de Sello/cirugía , Femenino , Estudios de Seguimiento , Gastrectomía , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/cirugía , Humanos , Corea (Geográfico) , Neoplasias Hepáticas/microbiología , Neoplasias Hepáticas/cirugía , Escisión del Ganglio Linfático , Metástasis Linfática , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Peritoneales/microbiología , Neoplasias Peritoneales/cirugía , Prevalencia , Pronóstico , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/cirugía , Tasa de SupervivenciaRESUMEN
Helicobacter pylori infection plays a central role in the development of gastric MALT-type (mucosa-associated lymphoid tissue) lymphoma. Infection results in chronic H. pylori gastritis and stimulates together with antigens or autoantigens proliferation of B-lymphocytes which is the basis for the neoplastic transformation. Histology of MALT-type lymphoma is architecturally similar to the physiological MALT. Invasion and destruction of the gastric epithelium with development of so-called lympho-epithelial lesions is the most important diagnostic criterion. Cytologically MALT-lymphoma resembles centrocytes and monocytes. For definitive lymphoma diagnosis and for the differential diagnosis from other small cell lymphomas in the stomach immunohistochemistry can be helpful. The phenotype of MALT-type lymphoma is identical to non-neoplastic B-lymphocytes of the marginal zone (CD20+, CD5-, CD10- and CD23-). Individual therapy is strongly dependent from histological type and lymphoma stadium. Therapy modalities are H. pylori eradication, radiochemotherapy, surgery or a combination of these. Aim of the therapy is the complete lymphoma regression and cure of the disease.
Asunto(s)
Infecciones por Helicobacter/complicaciones , Linfoma de Células B de la Zona Marginal/patología , Neoplasias Gástricas/patología , Antígenos CD/genética , Diagnóstico Diferencial , Endoscopía/métodos , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/radioterapia , Infecciones por Helicobacter/cirugía , Helicobacter pylori , Humanos , Inmunofenotipificación , Linfoma/patología , Linfoma de Células B de la Zona Marginal/diagnóstico , Linfoma de Células B de la Zona Marginal/genética , Linfoma de Células B de la Zona Marginal/terapia , Invasividad Neoplásica , Estadificación de Neoplasias , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/genética , Neoplasias Gástricas/terapiaRESUMEN
BACKGROUND: This experimental study was designed to determine if Helicobacter spp. contribute to benign gallbladder disease using polymerase chain reaction (PCR) methods. METHODS: Patients with benign gallbladder disease scheduled for elective cholecystectomy at New York University Langone Medical Center were recruited from February to May 2008. Bile, gallbladder tissue and gallstones were collected. DNA was isolated from these specimens and amplified via PCR using C97F and C98R primers specific for Helicobacter spp. Appropriate positive and negative controls were used. Products were analysed with agarose gel electrophoresis, sequenced and results aligned using sequencher. Plasma was collected for detection of anti-Helicobacter pylori antibodies via enzyme-linked immunosorbent assay. RESULTS: Of 36 patients, 12 patients' bile and/or tissue were positive for Helicobacter spp. by PCR. Species were most homologous with H. pylori, although other Helicobacter spp. were suggested. Six of 12 patients demonstrated anti-Helicobacter antibodies in plasma, suggesting that the remaining six might have demonstrated other species besides H. pylori. Four of six plasma samples with anti-Helicobacter antibodies were anti-CagA (cytotoxin associated gene) negative. DISCUSSION: Helicobacter spp. can be detected in bile and gallbladder tissue of patients with benign gallbladder disease. The contribution of these bacteria to the pathophysiology of gallbladder disease and gallstone formation requires further study.
Asunto(s)
Bilis/microbiología , Vesícula Biliar/microbiología , Cálculos Biliares/microbiología , Infecciones por Helicobacter/microbiología , Helicobacter pylori/aislamiento & purificación , Helicobacter/aislamiento & purificación , Adulto , Anciano , Antibacterianos/uso terapéutico , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/inmunología , Proteínas Bacterianas/inmunología , Colecistectomía , ADN Bacteriano/aislamiento & purificación , Procedimientos Quirúrgicos Electivos , Electroforesis en Gel de Agar , Ensayo de Inmunoadsorción Enzimática , Femenino , Vesícula Biliar/cirugía , Cálculos Biliares/cirugía , Helicobacter/genética , Helicobacter/inmunología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/genética , Helicobacter pylori/inmunología , Humanos , Masculino , Persona de Mediana Edad , Ciudad de Nueva York , Reacción en Cadena de la Polimerasa , Adulto JovenRESUMEN
Comparative analysis of results of surgical treatment, performed for perforative gastroduodenal ulcers in the patients, lacking H. pylori (control group) and owing this etiologic factor (main group), was conducted. Together with other conventional schemes of medicinal treatment in the early postoperative period a low-intensive irradiation of He-Ne laser was applied. Complete eradication of H. pylori was noted in 95.8% patients of the main group. In a late follow-up period (in 1-5 yrs observation terms) the frequency of recurrence, hemorrhage, pyloroduodenal stenosis and other surgical complications, occurring in the main group, was lesser than in a control one.
Asunto(s)
Infecciones por Helicobacter/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Úlcera Péptica Perforada/radioterapia , Úlcera Péptica Perforada/cirugía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Terapia Combinada , Femenino , Estudios de Seguimiento , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/aislamiento & purificación , Helicobacter pylori/efectos de la radiación , Humanos , Masculino , Persona de Mediana Edad , Úlcera Péptica Perforada/microbiología , Recurrencia , Resultado del Tratamiento , Adulto JovenRESUMEN
There were examined 35 patients after performance of operations for complicated ulcer disease. To the first group were incorporated 9 (25.7%) patients, in whom palliative operations were done, to the second group--9 (25.7%) patients, to whom vagotomy with gastric drainage operation was performed, and to the third group--17 (48.6%) patients, in whom gastric resections were applied. After palliative operations patholologic mucosal changes were localized predominantly in gastric antrum and duodenal ampulla. In 89% of observations mucosal pathology was associated with H. pylori. In 77.8% of the examined patients of second group the mucosal contamination by H. pylori was revealed. The relation was determined between gastric antrum mucosal inflammation and H. pylori infectioning. After gastric resection more significant signs of mucosal inflammation were observed in gastric stump and anastomotic region in comparison with such in efferent intestinal loop. Studying of gastroduodenal mucosa, using histological investigations after surgical treatment of complicated ulcer disease permits to reveal the character of mucosal pathological changes after performance of various operations and, taking it to account, to elaborate the individualized program of the patients rehabilitation.
Asunto(s)
Mucosa Gástrica/patología , Infecciones por Helicobacter/complicaciones , Mucosa Intestinal/patología , Cuidados Paliativos , Úlcera Péptica , Adulto , Duodeno/microbiología , Duodeno/patología , Duodeno/cirugía , Femenino , Mucosa Gástrica/microbiología , Mucosa Gástrica/cirugía , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/patología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/aislamiento & purificación , Humanos , Mucosa Intestinal/microbiología , Mucosa Intestinal/cirugía , Masculino , Úlcera Péptica/microbiología , Úlcera Péptica/patología , Úlcera Péptica/cirugía , Antro Pilórico/microbiología , Antro Pilórico/patología , Antro Pilórico/cirugíaRESUMEN
Gastric hyperplastic polyps (GHPs) have a potential risk of neoplastic transformation, but the responsible mechanisms have not yet been established. We conducted a study involving 55 patients (33 female) who had undergone endoscopic or surgical resection of GHPs. We compared 16 patients who had GHPs showing neoplastic transformation with 39 patients who had non-neoplastic GHPs. We analyzed differences in serology, gastroscopic manifestations and pathology between the two groups in order to establish risk factors that may be associated with neoplastic transformation. The mean age of the cohort was 61.73 ± 9.024 years. The prevalence of positive serum gastric parietal cell antibody (PCA) was 61.8%. 30 of the GHPs with neoplastic formation had a "strawberry-like" appearance with erosions of polyps (P = 0.000). A history of anaemia was a risk factor for GHPs which demonstrated neoplastic transformation (odds ratio [OR], 3.729; 95% confidence interval [CI], 1.099-12.649; P = 0.035). Although the differences were not significant, our data showed higher prevalences of positive serum PCA (P = 0.057), hypergastrinemia (P = 0.062) and female gender (P = 0.146) in the GHP patients who had neoplastic transformation. Multiple polyps in the corpus (P = 0.024) occurred more frequently in serum PCA positive patients. Hypergastrinemia occurred more frequently in Helicobacter pylori negative patients and of these 20/22 patients had a positive PCA (P = 0.007). GHPs are associated with autoimmune metaplastic atrophic gastritis (AMAG). AMAG is probably one of the risk factors for GHPs to undergo neoplastic transformation.
Asunto(s)
Pólipos Adenomatosos/sangre , Células Parietales Gástricas/metabolismo , Neoplasias Gástricas/sangre , Pólipos Adenomatosos/genética , Pólipos Adenomatosos/patología , Pólipos Adenomatosos/cirugía , Adulto , Anciano , Anticuerpos Antineoplásicos/sangre , Transformación Celular Neoplásica/genética , Endoscopía/métodos , Femenino , Infecciones por Helicobacter/sangre , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/patología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/patogenicidad , Humanos , Masculino , Persona de Mediana Edad , Células Parietales Gástricas/patología , Factores de Riesgo , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Neoplasias Gástricas/cirugíaRESUMEN
After endoscopic resection (ER) of gastric dysplasia, metachronous gastric neoplasm (MGN) appears to have an incidence rate similar to that detected after ER of early gastric cancer (EGC). We investigated whether the risk of MGN after ER for gastric dysplasia is different between patients with low-grade dysplasia (LGD) and high-grade dysplasia (HGD). Between March 2011 and December 2016, 198 patients with LGD (LGD group) and 46 patients with HGD (HGD group) who underwent ER were included in the study. During a median follow-up of 2.5 years, MGNs developed in 21 patients (10.6%) in the LGD group and in 6 patients (13.0%) in the HGD group. Hazard ratios (HRs) for MGNs (HR, 1.45; P = 0.425) and for metachronous HGD or gastric cancer (HR, 2.41; P = 0.214) in the HGD group were not different than those of the LGD group. However, considering patients without Helicobacter pylori infection, those in the HGD group had a significantly increased risk of metachronous HGD or gastric cancer compared to those in the LGD group (HR in HGD-group, 5.23; P = 0.044). These results indicate that meticulous surveillance endoscopy is needed to detect MGNs after ER of gastric dysplasia, especially in patients with HGD, including those without H. pylori infection.
Asunto(s)
Infecciones por Helicobacter/diagnóstico , Neoplasias Primarias Secundarias/etiología , Lesiones Precancerosas/complicaciones , Neoplasias Gástricas/etiología , Estómago/anomalías , Anciano , Progresión de la Enfermedad , Resección Endoscópica de la Mucosa/métodos , Femenino , Estudios de Seguimiento , Gastroscopía/métodos , Infecciones por Helicobacter/patología , Infecciones por Helicobacter/cirugía , Helicobacter pylori/crecimiento & desarrollo , Helicobacter pylori/patogenicidad , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Neoplasias Primarias Secundarias/diagnóstico , Neoplasias Primarias Secundarias/patología , Neoplasias Primarias Secundarias/cirugía , Oportunidad Relativa , Lesiones Precancerosas/diagnóstico , Lesiones Precancerosas/patología , Lesiones Precancerosas/cirugía , Estudios Retrospectivos , Factores de Riesgo , Estómago/cirugía , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/patología , Neoplasias Gástricas/cirugía , Factores de TiempoRESUMEN
BACKGROUND: The role of Helicobacter pylori (HP) in patients scheduled and undergoing laparoscopic sleeve gastrectomy (LSG) has not been previously evaluated. METHODS: Included were obese patients presenting to our institution for LSG over 24 months. All patients had presurgical HP breath test, and the symptomatic ones received triple therapy with symptom follow-up. Post surgery, all excluded stomachs were evaluated for HP, and those that were positive performed a second 13C-urea breath test (UBT) 3 months later. RESULTS: Forty patients underwent LSG. Male to female sex ratio was 1:3; mean age-42 years; mean weight-122 kg; and mean BMI of 43.4 kg/m2. Presurgical HP was positive in 15 (37.5%) patients (11 symptomatic and four asymptomatic). Only these 11 patients were given HP eradication therapy and all experienced complete subsequent symptom resolution. HP was detected in 17 out of the 40 (42.5%) cases of excluded stomachs. All performed a 13C-UBT 3 months post operation and only three (17.6%) tested positive. CONCLUSIONS: HP infection is frequent in biopsies from patients with previous LSG and the majority of follow-up 13C-UBT were negative. In our small initial sample, we treated only symptomatic patients preoperatively. Routine screening for HP for all LSG patients and/or treatment for all positive ones would subject patients to expensive and unnecessary investigations. We propose that this stomach-reducing, pylorus-preserving surgery might even lead to HP eradication. The clinical implications of HP and this gastrectomy for a non-neoplastic, non-peptic indication deserve further study.